Skip to main content
Log in

Second dose of measles vaccine

benefits outweigh costs

  • Newsletter Article
  • Published:
PharmacoEconomics & Outcomes News Weekly

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Second dose of measles vaccine. Pharmacoecon. Outcomes News 175, 9 (1998). https://doi.org/10.1007/BF03277706

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03277706

Keywords

Navigation